Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes.

Kumbhani DJ, Wells BJ, Lincoff AM, Jain A, Arrigain S, Yu C, Goormastic M, Ellis SG, Blackstone E, Kattan MW.

Am J Cardiovasc Dis. 2013;3(1):39-52. Epub 2013 Feb 17.

2.

Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.

Sengupta J, Kendig AC, Goormastic M, Hwang ES, Ching EA, Chung R, Lindsay BD, Tchou PJ, Wilkoff BL, Niebauer MJ, Martin DO, Varma N, Wazni O, Saliba W, Kanj M, Bhargava M, Dresing T, Taigen T, Ingelmo C, Bassiouny M, Cronin EM, Wilsmore B, Rickard J, Chung MK.

Heart Rhythm. 2012 Oct;9(10):1619-26. doi: 10.1016/j.hrthm.2012.07.002. Epub 2012 Jul 3.

3.

Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study.

Nicholls SJ, Sipahi I, Schoenhagen P, Wisniewski L, Churchill T, Crowe T, Goormastic M, Wolski K, Tuzcu EM, Nissen SE; ACTIVATE Investigators.

Am Heart J. 2006 Jul;152(1):67-74.

PMID:
16824833
4.

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators.

JAMA. 2006 Apr 5;295(13):1556-65. Epub 2006 Mar 13.

PMID:
16533939
5.

Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JF Jr, Hazen SL.

Circulation. 2004 Aug 31;110(9):1134-9. Epub 2004 Aug 23.

6.

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL.

J Clin Invest. 2004 Aug;114(4):529-41.

7.

Risk factors for hepatocellular carcinoma in patients with cirrhosis.

Sarbah SA, Gramlich T, Younoszai A, Osmack P, Goormastic M, Grosso L, Cooper JN, Di Bisceglie A, Seneca R, Younossi ZM.

Dig Dis Sci. 2004 May;49(5):850-3.

PMID:
15259508
8.

Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unit.

Aggarwal A, Ong JP, Goormastic M, Nelson DR, Arroliga AC, Farquhar L, Mayes J, Younossi ZM.

Transplant Proc. 2003 Dec;35(8):2998-3002.

PMID:
14697960
9.

Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old.

Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M, Topol EJ.

Am J Cardiol. 2003 Dec 15;92(12):1465-7.

PMID:
14675589
10.

Prognostic value of myeloperoxidase in patients with chest pain.

Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL.

N Engl J Med. 2003 Oct 23;349(17):1595-604.

11.

Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.

Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF Jr, Penn MS, Sprecher DL, Vita JA, Hazen SL.

JAMA. 2003 Apr 2;289(13):1675-80.

PMID:
12672736
12.

Determinants of the development of mitral regurgitation in pacing-induced heart failure.

Takagaki M, McCarthy PM, Goormastic M, Ochiai Y, Doi K, Kopcak MW Jr, Tabata T, Cardon LA, Thomas JD, Fukamachi K.

Circ J. 2003 Jan;67(1):78-82.

13.
14.

The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.

Avery RK, Pohlman BL, Mossad SB, Goormastic M, Longworth DL, Kalaycio ME, Sobecks RM, Andresen SW, Kuczkowski E, Bernhard L, Ostendorf H, Wise K, Bolwell BJ.

Bone Marrow Transplant. 2002 Sep;30(5):311-4.

15.

Medical versus surgical management of atherosclerotic renal artery stenosis.

Uzzo RG, Novick AC, Goormastic M, Mascha E, Pohl M.

Transplant Proc. 2002 Mar;34(2):723-5. No abstract available.

PMID:
12009679
16.

Telomerase activity in pancreatic endocrine tumors.

Tang SJ, Dumot JA, Wang L, Memmesheimer C, Conwell DL, Zuccaro G, Goormastic M, Ormsby AH, Cowell J.

Am J Gastroenterol. 2002 Apr;97(4):1022-30.

PMID:
12003383
17.

Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. 1989.

Novick AC, Streem S, Montie JE, Pontes JE, Siegel S, Montague DK, Goormastic M.

J Urol. 2002 Feb;167(2 Pt 2):878-82; discussion 883. No abstract available.

PMID:
11905915
18.

Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell lymphoma.

Bolwell B, Kalaycio M, Andresen S, Goormastic M, McBee M, Kuczkowski E, Wise K, Sobecks R, Pohlman B.

Clin Lymphoma. 2000 Dec;1(3):226-31; discussion 232-3.

PMID:
11707835
19.

Renal outcome 25 years after donor nephrectomy.

Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, Rolin HA, Flechner S, Goormastic M, Novick AC.

J Urol. 2001 Dec;166(6):2043-7.

PMID:
11696703
20.

Laparoscopic total colectomy for acute colitis: a case-control study.

Marcello PW, Milsom JW, Wong SK, Brady K, Goormastic M, Fazio VW.

Dis Colon Rectum. 2001 Oct;44(10):1441-5.

PMID:
11598472
21.

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices.

Gordon SM, Schmitt SK, Jacobs M, Smedira NM, Goormastic M, Banbury MK, Yeager M, Serkey J, Hoercher K, McCarthy PM.

Ann Thorac Surg. 2001 Sep;72(3):725-30.

PMID:
11565648
22.

Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer.

Bolwell B, Andresen S, Pohlman B, Sobecks R, Goormastic M, Rybicki L, Bell K, Kalaycio M.

Bone Marrow Transplant. 2001 Apr;27(8):843-6.

23.

Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection.

Yamani MH, Avery RK, Mawhorter SD, Young JB, Ratliff NB, Hobbs RE, McCarthy PM, Smedira NG, Goormastic M, Pelegrin D, Starling RC.

J Heart Lung Transplant. 2001 Apr;20(4):425-30.

PMID:
11295580
24.

The internal cardiac defibrillator for VT on LVAD support.

Roberts SR, Hoercher K, Mc Carthy PM, Smedira NG, Banbury MK, Goormastic M, Starling RC, Young J.

J Heart Lung Transplant. 2001 Feb;20(2):239. No abstract available.

PMID:
11250465
25.

Hospital transfer of patients for LVAD bridge to transplant: is timing really critical to success?

Hoercher K, McCarthy PM, Smedira N, Banbury MK, Starling RC, Buda TM, Goormastic M, Roberts SR, Young J.

J Heart Lung Transplant. 2001 Feb;20(2):209. No abstract available.

PMID:
11250378
26.
27.

Hypogammaglobulinemia in lung transplant recipients.

Goldfarb NS, Avery RK, Goormastic M, Mehta AC, Schilz R, Smedira N, Pien L, Haug MT, Gordon SM, Hague LK, Dresing JM, Evans-Walker T, Maurer JR.

Transplantation. 2001 Jan 27;71(2):242-6.

PMID:
11213067
28.

Results of partial left ventriculectomy for dilated cardiomyopathy: hemodynamic, clinical and echocardiographic observations.

Starling RC, McCarthy PM, Buda T, Wong J, Goormastic M, Smedira NG, Thomas JD, Blackstone EH, Young JB.

J Am Coll Cardiol. 2000 Dec;36(7):2098-103.

29.

Left ventricular reduction surgery with mitral valve repair.

McCarthy PM, Starling RC, Young JB, Smedira NG, Goormastic M, Buda T.

J Heart Lung Transplant. 2000 Aug;19(8 Suppl):S64-7.

PMID:
11016490
30.

Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma.

Copelan EA, Penza SL, Pohlman B, Avalos BR, Goormastic M, Andresen SW, Kalaycio M, Bechtel TP, Scholl MD, Elder PJ, Ezzone SA, O'Donnell LC, Tighe MB, Risley GL, Young DC, Bolwell BJ.

Bone Marrow Transplant. 2000 Jun;25(12):1243-8.

31.

The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.

Yamani MH, Starling RC, Goormastic M, Van Lente F, Smedira N, McCarthy P, Young JB.

Transplantation. 2000 Jun 15;69(11):2326-30.

PMID:
10868634
32.

Laparoscopic restorative proctocolectomy: case-matched comparative study with open restorative proctocolectomy.

Marcello PW, Milsom JW, Wong SK, Hammerhofer KA, Goormastic M, Church JM, Fazio VW.

Dis Colon Rectum. 2000 May;43(5):604-8.

PMID:
10826418
33.

Outcome of de novo hepatitis C virus infection in heart transplant recipients.

Ong JP, Barnes DS, Younossi ZM, Gramlich T, Yen-Lieberman B, Goormastic M, Sheffield C, Hoercher K, Starling R, Young J, Smedira N, McCarthy P.

Hepatology. 1999 Nov;30(5):1293-8.

PMID:
10534352
34.

Does the donor-recipient ABO blood group compatibility status predict subsequent lung transplantation outcomes?

Yu NC, Haug MT 3rd, Khan SU, Goormastic M, Hague LK, Mehta AC, Maurer JR.

J Heart Lung Transplant. 1999 Aug;18(8):764-8.

PMID:
10512522
35.

LDH elevation after autologous stem cell transplantation.

Bolwell B, Pohlman B, Kalaycio M, Wise K, Goormastic M, Andresen S.

Bone Marrow Transplant. 1999 Jul;24(1):53-5.

36.

A tool to identify risk factors for noncompliance in the adult renal transplant recipient.

Papajcik D, Mastroianni B, Goormastic M, Flechner SM.

Transplant Proc. 1999 Jun;31(4A):84S-86S. No abstract available.

PMID:
10372058
37.

Vitamin K reduces bleeding in left ventricular assist device recipients.

Kaplon RJ, Gillinov AM, Smedira NG, Kottke-Marchant K, Wang IW, Goormastic M, McCarthy PM.

J Heart Lung Transplant. 1999 Apr;18(4):346-50.

PMID:
10226899
38.

Monitoring of CMV infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture.

Flechner SM, Avery RK, Fisher R, Mastroianni B, Papajcik D, O'Malley KJ, Goormastic M, Goldfarb DA, Modlin CS, Novick AC.

Transplant Proc. 1999 Feb-Mar;31(1-2):1255-7. No abstract available.

PMID:
10083560
39.

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.

Flechner SM, Avery RK, Fisher R, Mastroianni BA, Papajcik DA, O'Malley KJ, Goormastic M, Goldfarb DA, Modlin CS, Novick AC.

Transplantation. 1998 Dec 27;66(12):1682-8.

PMID:
9884259
40.

Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.

Bolwell B, Goormastic M, Andresen S, Koo A, Wise K, Overmoyer B, Pohlman B, Kalaycio M.

Bone Marrow Transplant. 1998 Sep;22(6):547-51.

41.

Long-term survival in patients with mild or moderate impairment of left ventricular contractility during routine diagnostic left ventriculography.

Grinfeld L, Kramer JR Jr, Goormastic M, Aydinlar A, Proudfit WL.

Cathet Cardiovasc Diagn. 1998 Jul;44(3):283-90.

PMID:
9676797
42.

Risk factors for death after heart transplantation: does a single-center experience correlate with multicenter registries?

McCarthy JF, McCarthy PM, Massad MG, Cook DJ, Smedira NG, Kasirajan V, Goormastic M, Hoercher K, Young JB.

Ann Thorac Surg. 1998 Jun;65(6):1574-8; discussion 1578-9.

PMID:
9647061
43.

Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure.

McCarthy JF, McCarthy PM, Starling RC, Smedira NG, Scalia GM, Wong J, Kasirajan V, Goormastic M, Young JB.

Eur J Cardiothorac Surg. 1998 Apr;13(4):337-43.

PMID:
9641329
44.

One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology.

McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, Young JB.

J Thorac Cardiovasc Surg. 1998 Apr;115(4):904-12.

45.

Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial.

Bolwell BJ, Pohlman B, Andresen S, Kalaycio M, Goormastic M, Wise K, Wakeling A, Dannley R, Overmoyer B.

Bone Marrow Transplant. 1998 Feb;21(4):369-73.

46.

High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients.

Gupta A, Moustapha A, Jacobsen DW, Goormastic M, Tuzcu EM, Hobbs R, Young J, James K, McCarthy P, van Lente F, Green R, Robinson K.

Transplantation. 1998 Feb 27;65(4):544-50.

PMID:
9500631
47.

A randomized study of multi-day infusion of autologous peripheral blood progenitor cells.

Abdel-Razeq H, Pohlman B, Andresen S, Kalaycio M, Overmoyer B, Wise K, Dannley R, DeMars D, Goormastic M, Bolwell B.

Bone Marrow Transplant. 1998 Feb;21(3):221-3.

48.

A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment.

Sandhaus LM, Edinger MG, Tubbs RR, Goormastic M, Baucco PA, Serafino SE, Bolwell BJ.

Exp Hematol. 1998 Jan;26(1):73-8.

PMID:
9430516
49.

Progressive disease after ABMT for Hodgkin's disease.

Bolwell BJ, Kalaycio M, Goormastic M, Dannley R, Andresen SW, Lichtin A, Overmoyer B, Pohlman B.

Bone Marrow Transplant. 1997 Nov;20(9):761-5.

50.

Early results with partial left ventriculectomy.

McCarthy PM, Starling RC, Wong J, Scalia GM, Buda T, Vargo RL, Goormastic M, Thomas JD, Smedira NG, Young JB.

J Thorac Cardiovasc Surg. 1997 Nov;114(5):755-63; discussion 763-5.

Supplemental Content

Loading ...
Support Center